Table 2. Levels of ESM-1 in MPE and association with the clinicopathological factors of NSCLC patients.
Clinical variables | Number | ESM-1(ng/ml) | P-value |
---|---|---|---|
Age (years) | 0.563 | ||
≥ 65 | 23 | 54.93 ± 8.12 | |
< 65 | 47 | 49.33 ± 5.46 | |
Gender | 0.930 | ||
Male | 40 | 50.82 ± 5.53 | |
Female | 30 | 51.63 ± 7.61 | |
Histological type | 0.756 | ||
Adenocarcinoma | 53 | 51.97 ± 5.36 | |
Squamous cell carcinoma | 17 | 48.6 7 ± 8.30 | |
Performance Status | 0.515 | ||
0 to 1 | 35 | 48.20 ± 6.20 | |
2 to 4 | 35 | 54.14 ± 6.59 | |
Smoking status | 0.138 | ||
Nonsmoker | 36 | 44.65 ± 6.00 | |
Smoker | 34 | 58.07 ± 6.65 | |
Tumor size (cm) | 0.218 | ||
≤ 5 | 41 | 46.47 ± 5.17 | |
> 5 | 29 | 57.82 ± 8.01 | |
Distant metastasis | 0.020a | ||
Absent | 31 | 39.18 ± 5.34 | |
Present | 39 | 60.16 ± 6.49 |
aSignificant difference.